Concert Pharmaceuticals Inc (CNCE) Insider Trading
- $10,069,543.44
- $67,321,372.05
- Feb. 15, 2023
- Nancy Stuart
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Feb. 15, 2023 | Insider | 3,762 | $8.34 | Sell | $31,375.08 | |
Feb. 15, 2023 | COO | 6,048 | $8.33 | Sell | $50,379.84 | |
Jan. 30, 2023 | COO | 13,200 | $8.35 | Sell | $110,220.00 | |
Jan. 30, 2023 | Insider | 8,493 | $8.35 | Sell | $70,916.55 | |
Jan. 6, 2023 | CEO | 9,240 | $7.24 | Sell | $66,897.60 | |
Jan. 6, 2023 | COO | 2,893 | $7.25 | Sell | $20,974.25 | |
Oct. 14, 2022 | Director | 3,539 | $6.09 | Sell | $21,552.51 | |
June 6, 2022 | Director | 10,526 | $4.75 | Buy | $49,998.50 | |
Feb. 15, 2022 | CEO | 13,480 | $3.09 | Sell | $41,653.20 | |
Feb. 14, 2022 | Insider | 3,762 | $3.09 | Sell | $11,624.58 | |
Feb. 14, 2022 | COO | 6,049 | $3.08 | Sell | $18,630.92 | |
Jan. 6, 2022 | CEO | 9,240 | $3.09 | Sell | $28,551.60 | |
Jan. 5, 2022 | COO | 2,894 | $3.19 | Sell | $9,231.86 | |
Dec. 13, 2021 | CEO | 6,700 | $3.62 | Sell | $24,254.00 | |
Aug. 16, 2021 | Insider | 8,086 | $3.28 | Sell | $26,522.08 | |
Aug. 16, 2021 | CFO | 7,304 | $3.28 | Sell | $23,957.12 | |
Feb. 17, 2021 | CEO | 13,480 | $7.20 | Sell | $97,056.00 | |
Feb. 16, 2021 | Insider | 3,763 | $7.32 | Sell | $27,545.16 | |
Feb. 16, 2021 | COO | 6,049 | $7.32 | Sell | $44,278.68 | |
June 22, 2020 | COO | 10,295 | $11.34 | Sell | $116,745.30 | |
March 12, 2020 | Director | 1,500 | $8.52 | Buy | $12,780.00 | |
Feb. 3, 2020 | Director | 1,000 | $10.91 | Buy | $10,910.00 | |
Oct. 8, 2019 | Director | 5,000 | $5.90 | Buy | $29,500.00 | |
Aug. 8, 2019 | Director | 3,539 | $10.31 | Sell | $36,487.09 | |
Aug. 2, 2019 | Director | 5,000 | $10.84 | Buy | $54,200.00 | |
June 10, 2019 | Major Shareholder | 386,289 | $10.70 | Sell | $4,133,292.30 | |
Nov. 15, 2018 | Director | 50,000 | $11.83 | Buy | $591,500.00 | |
July 10, 2018 | COO | 31,418 | $17.87 | Sell | $561,439.66 | |
April 17, 2018 | Insider | 10,582 | $20.18 | Sell | $213,544.76 | |
Feb. 1, 2018 | Director | 11,946 | $20.89 | Sell | $249,551.94 | |
Jan. 29, 2018 | Director | 18,054 | $20.63 | Sell | $372,454.02 | |
Jan. 26, 2018 | Director | 5,000 | $20.46 | Sell | $102,300.00 | |
Jan. 24, 2018 | Director | 30,000 | $19.68 | Sell | $590,400.00 | |
Jan. 22, 2018 | Director | 10,000 | $19.55 | Sell | $195,500.00 | |
Jan. 19, 2018 | Director | 30,000 | $19.35 | Sell | $580,500.00 | |
Jan. 16, 2018 | Director | 31,236 | $19.14 | Sell | $597,857.04 | |
Dec. 19, 2017 | Insider | 1,282,856 | $26.65 | Sell | $34,188,112.40 | |
Dec. 4, 2017 | Director | 14,156 | $24.70 | Sell | $349,653.20 | |
Oct. 19, 2017 | Insider | 331,916 | $15.84 | Buy | $5,257,549.44 | |
Sept. 14, 2017 | Insider | 3,500 | $14.51 | Sell | $50,785.00 | |
May 12, 2016 | Director | 2,000 | $10.11 | Buy | $20,220.00 | |
May 11, 2016 | CEO | 19,610 | $10.55 | Buy | $206,885.50 | |
Dec. 16, 2015 | Director | 10,360 | $19.57 | Sell | $202,745.20 | |
Dec. 15, 2015 | Director | 54,572 | $20.10 | Sell | $1,096,897.20 | |
Dec. 14, 2015 | Director | 3,922 | $20.09 | Sell | $78,792.98 | |
Dec. 14, 2015 | VP | 498 | $20.07 | Sell | $9,994.86 | |
Nov. 9, 2015 | Director | 17,699 | $22.27 | Sell | $394,156.73 | |
Nov. 2, 2015 | COO | 23,216 | $24.29 | Sell | $563,916.64 | |
Sept. 18, 2015 | VP | 10,000 | $20.00 | Sell | $200,000.00 | |
Sept. 10, 2015 | Director | 120,000 | $18.22 | Sell | $2,186,400.00 |
Insiders are both buying and selling Concert Pharmaceuticals Inc stock.
The insider traders at Concert Pharmaceuticals Inc are: Nancy Stuart, Richard Aldrich, Wilfred E Jaeger, Roger D Tung, Jeffrey A Munsie, Thomas G Auchincloss, Heek Christi Van, Pauline Mcgowan, James V Cassella, Peter Barton Hutt, Value Fund L P Biotechnology, Robert Silverman, Three Arch Management Iv, L.L., Marc A Becker, Bvf Partners L P/Il, Plc Glaxosmithkline, Life Science Ventures Vi G Tvm, Ronald W Barrett, Ronald W. Barrett, Ryan Lynch, and Skyline Venture Partners Quali
The most active insider trader at Concert Pharmaceuticals Inc is Nancy Stuart with 10 trades.
Value Fund L P Biotechnology has sold the most Concert Pharmaceuticals Inc stock with a total value of $68,376,224.80.
Value Fund L P Biotechnology has bought the most Concert Pharmaceuticals Inc stock with a total value of $10,515,098.88.
The most recent insider trade for Concert Pharmaceuticals Inc was on Feb. 15, 2023.
The single biggest insider buy for Concert Pharmaceuticals Inc was from Value Fund L P Biotechnology with a total value of $5,257,549.44 on Oct. 19, 2017.
The single biggest insider sell for Concert Pharmaceuticals Inc was from Value Fund L P Biotechnology with a total value of $34,188,112.40 on Dec. 19, 2017.